Person Julie
Person Julie, CPO, reported a transaction classified as grant at Aura Biosciences, Inc. involving 107611.000000 shares for an estimated $0.00. Reported holdings after the transaction were 107611.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 01, 2026
- Filing date
- Sep 01, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
AURA price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0001946505-26-000009 Common Stock
- Transaction date
- Sep 01, 2026 Filed Sep 01, 2026, 09:28 PM · 0d delay
- Shares
- 107,611 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 107,611 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-12 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 0
Filing reported within two business days of the transaction. - grant_or_award-22 points
transaction_code = A
Grant or award transactions are scheduled compensation, not discretionary.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief People Officer
- F1
These securities represent an inducement award granted pursuant to a restricted stock unit ("RSU") award agreement with the Issuer. Each RSU represents the right to receive one share of the Issuer's C…
- F2
The option shall vest as follows: 25% of the options vest on August 12, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued serv…
0 other transactions
0 recent txs